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ELISA, and then genotypes and subgenotypes was identiﬁed on
four modes by using genotype-speciﬁc-primer PCR and nested
polymerase chain reaction-restriction fragment length polymor-
phism (nested PCR-RFLP) and 5 cases of identiﬁed genotypes
were randomly selected for directly sequencing their S gene to
verify the accuracy of genotype-speciﬁc-primer PCR.
Result: 1. 57 samples were tested for the positive of HBV
genotype,of which exist 34 genotype B,12 genotype C and 11
genotype B+C mixed, Genotype B is more prevalent in our group;
There were 37 HBV subgenotype positive in identiﬁed genotype
samples, of which exist 24 subgenotype Ba, 12 subgenotype Cs
and 1 subgenotype Ce, Ba was main subgenotype in the group. 2.
The HBV infection factors such as age,gender and marital status
was not statistically signifycant except nation (p=0.0001).
Conclusion: The Result show: 1. Genotype B and subgenotype
Ba were the predominant strains in the minority groups of Yun-
nan province. 2. Nation and the positive rate of HBsAg showed
correlatitive, but age, gender and marital status existed no
difference.
PP-076 Diagnostic values of transforming growth factor
(TGF)-β1 and TGF-β1 mRNA in HBV-related
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Background: To investigated the characteristics of TGF-β1 and
TGF-β1-mRNA expression, their relationship with HBV replica-
tion, and their diagnostic values for HCC.
Methods: Total RNAs were extracted from HCC tissues and their
matched non-tumor tissues, or from PBMCs in HCC patients. TGF-
β1 mRNA were ampliﬁed by RT-PCR and conﬁrmed by sequencing.
TGF-β1 expression was examined by immunohistochemistry. The
clinical characteristics were analyzed between TGF-β1 and HBV
replication. Diagnostic values of TGF-β1 and TGF-β1 mRNA were
investigated.
Results: The incidence of TGF-β1 expression was 83.3% in HCC,
43.3% in their surrounding tissues, 94.7% in HBV-DNA-positive
group, and 63.6% in HBV-DNA-negative one, respectively. TGF-β1
expression were associated with the degree of HCC differentia-
tion and the statue of HBV replication, but neither to size nor to
number of tumors. Circulating TGF-β1 level or incidence of TGF-
β1 mRNA was signiﬁcantly higher in HCC group than any group of
patients with benign liver diseases, with higher sensitivity (89.5%)
and speciﬁcity (94.0%) for HCC diagnosis when TGF-β1 level (>
1.2 μg/L). No signiﬁcant correlation was found between TGF-β1
expression and AFP levels or tumor sizes. Combined TGF-β1 level
and serum AFP could raise the detection rate up to 97.4%.
Conclusion: The abnormal expression of TGF-β1 was associated
with degree of HCC differentiation and HBV replication. Both of
TGF-β1 and TGF-β1-mRNA could be used as sensitive biomarkers
for diagnosis and prognosis of HBV-related HCC.
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Infectious Disease, Third Afﬁliated Hospital of Hebei Medical
University, Shijiazhuang, China; 2Department of Central
Laboratory, Third Afﬁliated Hospital of Hebei Medical
University, Shijiazhuang, China; 3Department of Laboratory,
The Fifth Hospital of Shijiazhuang,China
Background: Hepatic steatosis is common in chronic hepatitis B
(CHB) patients. The aim of this study was to investigate the effect
and signiﬁcance of hepatic steatosis to CD4+CD25+ regulatory T
cells (Tregs) in CHB patients.
Methods: Tregs in peripheral blood and expression of Foxp3 in
liver tissue were examined by ﬂow cytometry and immunohisto-
chemistry respectively. HBV markers, alanine aminotransferase
(ALT) and HBV DNA levels were measured in each subject.
Results: ALT, HBV DNA and the inﬂammatory grade (G) of liver
tissue in patients who had CHB plus hepatic steatosis were similar
to CHB group; The percentage of Tregs in peripheral blood of pa-
tients with CHB plus hepatic steatosis was lower than that in CHB
patients but higher than control group, which was coincided with
the change of Foxp3 positive Tregs in liver tissue; The percentage
of Tregs in high ALT group was higher compared with low ALT
group; The inﬂammatory grade of liver tissue in 14 patients was
G2, in other 16 patients was G3, Foxp3 positive Tregs in the latter
group were more than those in the former group; The percentage
of Tregs was not associated with HBV DNA level.
Conclusion: Tregs in peripheral blood and liver tissue of patients
with CHB plus hepatic steatosis are fewer compared with CHB
patiens, and Tregs have a close relation with hepatic inﬂam-
mation. The decreased Tregs may lead to a lower suppression
of inﬂammatory response, further more, the progression of CHB
would be accelerated.
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Objective: to investigate the signiﬁcance of the inhibition of NF-
κB in D-galactosamine + Lipopolysaccharide-induced fulminant
hepatic failure.
Methods: 60 Wistar rat were divided randomly to model group
and PDTC group, which has 30 rats respectively. The serum
and liver tissue were maintained. Hepatic tissue was observed
by Routine HE staining; The levels of serum ALT and TB were
detected by automatic biochemical analyzer. The changes of
serum NO were detected by using nitrate reductase assay. The
expression of NF-κB and iNOS mRNA were detected by RT-PCR.
Results: 1. The inﬂammation and necrosis were reduced in PDTC
group. 2. Except for 8 hour, the ALT levels were lower than that
of the model group (P<0.05). The TB level were lower than the
model group at 4, 12, 24 hour, and the difference had statistical
signiﬁcance (P<0.05). NO of the serum in model group were
lower than that of model group at 2, 8, 12 hour, and the differ-
ence had statistical signiﬁcance (P<0.05). 3. At 4, 8 hour, the
expression of NF-κB mRNA in PDTC group was lower than model
group at corresponding different time. And the difference had
statistical signiﬁcance (P<0.05). At 4 and 8 hour, the expression
of iNOS mRNA in PDTC group was lower than that of model group
at corresponding different time (P<0.05).
Conclusion: NF-κB plays an important role in the hepatic inﬂam-
mation of D-GalN+LPS-induced fulminant hepatic failure. PDTC
can attenuate hepatic inﬂammation and necrosis through the
inhibition of NF-κB.
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Background: To investigate the correlation between the risk fac-
tors and prognosis of chronic hepatic failure and try to construct
the prognostic model.
Methods: All 28 patients with chronic hepatic failure were di-
